AI assistant
STRATA Skin Sciences, Inc. — Director's Dealing 2015
Aug 24, 2015
35146_dirs_2015-08-24_55d53c5b-6507-4d06-bc7e-0c093a8912ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MELA SCIENCES, INC. /NY (MELA)
CIK: 0001051514
Period of Report: 2015-08-11
Reporting Person: Broadfin Capital, LLC (10% Owner)
Reporting Person: Broadfin Healthcare Master Fund Ltd (10% Owner)
Reporting Person: KOTLER KEVIN (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1274297 | Direct |
| Common Stock | 1274297 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Warrant | $7.40 | 2019-02-05 | Common Stock, $0.001 par value per share (432432) | Direct | |
| Common Stock Warrant | $7.40 | 2019-02-05 | Common Stock, $0.001 par value per share (432432) | Indirect | |
| Common Stock Warrant | $2.45 | 2019-07-24 | Common Stock, $0.001 par value per share (1267849) | Direct | |
| Common Stock Warrant | $2.45 | 2019-07-24 | Common Stock, $0.001 par value per share (1267849) | Indirect | |
| Common Stock Warrant | $2.45 | 2016-01-24 | Common Stock, $0.001 par value per share (1559454) | Direct | |
| Common Stock Warrant | $2.45 | 2016-01-24 | Common Stock, $0.001 par value per share (1559454) | Indirect | |
| Common Stock Warrant | $0.75 | 2020-06-22 | Common Stock, $0.001 par value per share (1500000) | Direct | |
| Common Stock Warrant | $0.75 | 2020-06-22 | Common Stock, $0.001 par value per share (1500000) | Indirect | |
| Senior Convertible Debenture | $ | 2019-07-24 | Common Stock, $0.001 par value per share (377177) | Direct | |
| Senior Convertible Debenture | $ | 2019-07-24 | Common Stock, $0.001 par value per share (377177) | Indirect | |
| Senior Convertible Debenture | $ | 2020-06-22 | Common Stock, $0.001 par value per share (20000000) | Direct | |
| Senior Convertible Debenture | $ | 2020-06-22 | Common Stock, $0.001 par value per share (20000000) | Indirect |
Footnotes
F1: The securities are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
F2: Broadfin Capital, LLC shall not have the right to exercise the Warrants to purchase shares of common stock, to the extent that, after giving effect to the conversion or exercise, Broadfin Capital, LLC (directly or indirectly) would beneficially own in excess of 9.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon exercise of the Warrants held by Broadfin Capital, LLC.
F3: These debentures (the "Debentures") are convertible into shares of common stock at a conversion price of $2.565 per common share of the Issuer. The Debentures bear interest at an annual rate of 4%, payable quarterly or upon conversion into shares of common stock of the Issuer.
F4: These Debentures are convertible into shares of common stock at a conversion price of $0.75 per share of the Issuer. The Debentures bear interest at the rate of 2.25% per year. Under the terms of the Debentures, the issuances of shares of the common stock upon conversion are subject to the approval by the Issuer's stockholders.